[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-353764-105":59,"doc-detail-353764-en":134},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":127,"head_meta":129,"extra_data":131,"updated_unix":133},105,"en","correlation-between-pd-l1-expression-and-clinical-pathology-immunobiological-markers-and-prognosis-in-gastroenteropancreatic-neuroendocrine-neoplasms-a-systematic-review-and-meta-analysis","Correlation between PD-L1 expression and clinical pathology, immunobiological markers, and prognosis in gastroenteropancreatic neuroendocrine neoplasms - A systematic review and meta-analysis","","Advanced gastroenteropancreatic neuroendocrine neoplasms (GEP-NENs) have limited therapeutic options, and the clinical meaning of programmed death-ligand 1 (PD-L1) remains disputed across clinicopathology, immune markers, and outcomes. This systematic review and meta-analysis searched major databases up to November 2025, extracted data independently, and pooled results using odds ratios and hazard ratios with fixed/random-effects models. Twenty-two studies (1,872 patients) showed high PD-L1 expression linked to aggressive features and worse overall survival.",{"@graph":69,"@context":126},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/correlation-between-pd-l1-expression-and-clinical-pathology-immunobiological-markers-and-prognosis-in-gastroenteropancreatic-neuroendocrine-neoplasms-a-systematic-review-and-meta-analysis/353764/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/correlation-between-pd-l1-expression-and-clinical-pathology-immunobiological-markers-and-prognosis-in-gastroenteropancreatic-neuroendocrine-neoplasms-a-systematic-review-and-meta-analysis/353764.png","ImageObject",300,407,{"name":92,"@type":93},"Riley","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-23","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":34},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118,122],{"name":109,"@type":110,"acceptedAnswer":111},"What was the objective of this systematic review and meta-analysis?","Question",{"text":112,"@type":113},"To clarify the relationship between PD-L1 expression and clinicopathological features, immunobiological markers, and prognosis in gastroenteropancreatic neuroendocrine neoplasms.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How many studies and patients were included, and how were study quality and data handled?",{"text":117,"@type":113},"Twenty-two studies with 1,872 patients were included. Two researchers independently extracted data and assessed quality using the Newcastle-Ottawa Scale, and pooled analyses used Stata 17.0 with odds ratios or hazard ratios and 95% confidence intervals.",{"name":119,"@type":110,"acceptedAnswer":120},"Which clinical or immune markers were associated with high PD-L1 expression?",{"text":121,"@type":113},"High PD-L1 expression was significantly associated with higher tumor grade, poorer differentiation, increased PD-1 expression, and shorter overall survival.",{"name":123,"@type":110,"acceptedAnswer":124},"Did the review find associations between PD-L1 and factors like age or tumor stage?",{"text":125,"@type":113},"No significant associations were found between PD-L1 expression and sex, age, histological type, tumor stage, invasion, metastasis, CD8+ T cell/FOXP3+ T cell infiltration, or mismatch repair status.","https://schema.org",{"og:url":83,"og:type":128,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":130,"canonical":83},"index,follow",{"doc_id":132,"site_id":62},353764,1790488831,{"code":4,"msg":5,"data":135},{"doc_id":132,"user_id":136,"nickname":92,"user_avatar":137,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":138,"file_id":139,"file_url":140,"file_type":141,"file_size":142,"view_count":34,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":143,"language":144,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":145,"faqs":146,"seo_title":147,"seo_description":67,"update_tm":148,"read_time":149,"preview_page_count":19,"preview_urls":150},1374391975076,"https://ap-avatar.wpscdn.com/avatar/14000253ca4ec9f6853?x-image-process=image/resize,m_fixed,w_180,h_180&k=1783305029341752051","TYPE Systematic Review PUBLISHED 12 February 2026 DOI 10.3389/fimmu.2026.1772011  \nOPEN ACCESS  \nEDITED BY  \nEyad Elkord,  \nXi’an Jiaotong-Liverpool University, China  \nREVIEWED BY  \nSaifullah Afridi,  \nKohat University Of Science And Technology, Pakistan  \nJasmeet Kaur,  \nFox Chase Cancer Center, United States  \n*CORRESPONDENCE  \nChiyi Chen  \n[ccy_616@126.com](ccy_616@126.com)[ ](ccy_616@126.com)Wentao Jiang  \n[jiangwentao@nankai.edu.cn](jiangwentao@nankai.edu.cn)[ ](jiangwentao@nankai.edu.cn)†These authors have contributed equally to this work and share ﬁrst authorship  \nRECEIVED 20 December 2025  \nREVISED 19 January 2026  \nACCEPTED 27 January 2026  \nPUBLISHED 12 February 2026  \nCITATION  \nZheng Q, Jin S, Xie X, Guo Q, Chen Cand Jiang W (2026) Correlation between PD-L1 expression and clinical pathology, immunobiological markers, and prognosis in gastroenteropancreatic neuroendocrine neoplasms: a systematic review and meta-analysis.  \nFront. Immunol. 17:1772011 .  \ndoi: 10.3389/fimmu.2026.1772011  \nCOPYRIGHT  \n© 2026 Zheng, Jin, Xie, Guo, Chen and Jiang. This is an open-access article distributed under the terms of the  \nCreative Commons Attribution License (CC BY) . The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.  \nCorrelation between  \nPD-L1 expression and clinical pathology, immunobiological markers, and prognosis ingastroenteropancreatic neuroendocrine neoplasms:  \na systematic review and meta-analysis  \nQiming Zheng 1,2,3,4†, Shangbo Jin 5†, Xinyue Xie 1,2,3,4†,  \nQingjun Guo 1,2,3,4, Chiyi Chen 1,2,3,4* and Wentao Jiang 1,2,3,4,6* 1 Department of General Surgery/Transplantation, First Central Hospital of Tianjin Medical University, Tianjin, China, 2 Department of Liver Transplantation, Tianjin First Central Hospital, Tianjin, China,  \n3Tianjin Key Laboratory of Molecular Diagnosis and Treatment of Liver Cancer, Tianjin First Center Hospital, Tianjin, China, 4Tianjin Key Laboratory for Organ Transplantation, Tianjin First Center Hospital, Tianjin, China, 5 Department of Hepatobiliary Pancreatic Spleen Surgery, Baoji People’s Hospital, Baoji, Shaanxi, China, 6 Institute of Transplantation Medicine, Nankai University, Tianjin, China  \nBackground: Advanced gastroenteropancreatic neuroendocrine neoplasms (GEP-NENs) have limited therapeutic options. The role of programmed deathligand 1 (PD-L1) in their clinicopathology, immune markers, and prognosis remains controversial. This meta-analysis aimed to systematically clarify these relationships.  \nMethods: We searched Medline/PubMed, Web of Science, Embase, and Cochrane Library from inception to November 2025 for studies on PD-L1 expression in GEP-NENs. Two researchers independently extracted data and assessed quality via Newcastle-Ottawa Scale (NOS) . Pooled analyses were conducted using Stata 17.0, with odds ratio (OR)/hazard ratio (HR) and 95% conﬁdence interval (CI) as effect indicators, and ﬁxed/random-effects models chosen by heterogeneity.  \nResults: A total of 22 studies involving 1,872 patients (17 high-quality and 5 moderate-quality) were included. High PD-L1 expression was signiﬁcantly associated with higher tumor grade (OR = 3.78, 95% CI:2.04-7.01; p\u003C0.001), poorer differentiation (OR = 2.80, 95% CI:1.18-6.65; p=0.020), increased PD-1 expression (OR = 4.15, 95% CI:2.16-7.99; p\u003C0.001), and shorter overall survival (HR = 1 . 66, 95% CI:1 .32-2. 10; p\u003C0 . 001) . No signiﬁcant associations were found with sex, age, histological type, tumor stage, invasion, metastasis, CD8+ T cell/ FOXP3+ T cell inﬁltration, or mismatch repair (MMR) status. No publication bias existed.  \nFrontiers in Immunology 01 [frontiersin.org](frontiersin.org)  \nConclusion: High PD-L1 expression in GEP-NENs correlate","cbCairs97iHZTDfG","https://ap.wps.com/l/cbCairs97iHZTDfG","pdf",2398376,13,"English","# Background\n# Methods\n# Results\n# Conclusion\n# Systematic review registration","[{\"question\":\"What was the objective of this systematic review and meta-analysis?\",\"answer\":\"To clarify the relationship between PD-L1 expression and clinicopathological features, immunobiological markers, and prognosis in gastroenteropancreatic neuroendocrine neoplasms.\"},{\"question\":\"How many studies and patients were included, and how were study quality and data handled?\",\"answer\":\"Twenty-two studies with 1,872 patients were included. Two researchers independently extracted data and assessed quality using the Newcastle-Ottawa Scale, and pooled analyses used Stata 17.0 with odds ratios or hazard ratios and 95% confidence intervals.\"},{\"question\":\"Which clinical or immune markers were associated with high PD-L1 expression?\",\"answer\":\"High PD-L1 expression was significantly associated with higher tumor grade, poorer differentiation, increased PD-1 expression, and shorter overall survival.\"},{\"question\":\"Did the review find associations between PD-L1 and factors like age or tumor stage?\",\"answer\":\"No significant associations were found between PD-L1 expression and sex, age, histological type, tumor stage, invasion, metastasis, CD8+ T cell/FOXP3+ T cell infiltration, or mismatch repair status.\"}]","Correlation between PD-L1 expression and clinical pathology, immunobiological markers, and prognosis in gastroenteropancreatic neuroendocrine neoplasms - A systematic review and meta-analysis | PDF",1790107118,33,[151,155,159,163],{"page_no":8,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/0c450236dcbc9e071fadd22ab0c8acd7.webp",983,1389,{"page_no":14,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/8c1011bb6110723da7d4f605267964cc.webp",982,1388,{"page_no":81,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/1da80802b7e162a242563b6c14a44830.webp",981,1386,{"page_no":19,"url":164,"width":165,"height":166},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/6e32064ccb0f70be8005d91b087d4aa3.webp",980,1385]